• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF

+ Add to Watchlist

1621:JP

14,260.0000 JPY 40.0000 0.28%

As of 00:16:07 ET on 04/18/2014.

Snapshot for Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF (1621)

Open: 14,320.0000 High - Low: 14,320.0000 - 14,260.0000 Primary Exchange: Tokyo
Volume: 37 52-Week Range: 12,610.0000 - 15,820.0000 Beta vs TP17PHRM: 0.9461

ETF Chart for 1621

No chart data available.
  • 1621:JP 14,260.0000
  • 1D
  • 1M
  • 1Y
14,300.0000
Interactive 1621 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1621

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated in Japan. The objective of the Fund is to provide investment results that correspond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-03-25 Telephone: 81-3-3241-9511
Managers: -
Web Site: www.nomura-am.co.jp

Fundamentals for 1621

NAV (on 2014-04-18) 14,341.5000
Assets (M) (on 2014-04-18) 595.0000
Shares out (M) 0.04
Market Cap (M) 591.46
% Premium -0.57
Average 52-Week % Premium -0.1128
Fund Leveraged N

Dividends for 1621

Dividend Type Distribution
Dividend Frequency Annual
Last Dividend Net (on 2013-07-10) 221.0000
Dividend Yield (ttm) 1.55%

Performance for 1621

1-Month -2.86% 1-Year -2.93%
3-Month -6.55% 3-Year +14.45%
Year To Date -5.00% 5-Year +10.30%
Expense Ratio 0.32

Top Fund Holdings for 1621

Filing Date: 03/31/2014
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 30,800 150,673,600 24.145%
Astellas Pharma Inc 94,700 115,912,800 18.574%
Otsuka Holdings Co Ltd 16,300 50,318,100 8.063%
Daiichi Sankyo Co Ltd 25,900 45,014,200 7.213%
Eisai Co Ltd 10,100 40,581,800 6.503%
Ono Pharmaceutical Co Ltd 3,700 33,078,000 5.301%
Shionogi & Co Ltd 12,800 24,486,400 3.924%
Chugai Pharmaceutical Co Ltd 8,200 21,607,000 3.462%
Taisho Pharmaceutical Holdings 2,000 16,620,000 2.663%
Santen Pharmaceutical Co Ltd 3,000 13,740,000 2.202%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil